STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

STAAR Surgical Co
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

STAAR Surgical Co
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Other Current Assets
$12.8m
CAGR 3-Years
18%
CAGR 5-Years
28%
CAGR 10-Years
16%
Haemonetics Corp
NYSE:HAE
Other Current Assets
$61m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Other Current Assets
$75.8m
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
20%
Align Technology Inc
NASDAQ:ALGN
Other Current Assets
$290.7m
CAGR 3-Years
23%
CAGR 5-Years
86%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Other Current Assets
$29.2m
CAGR 3-Years
34%
CAGR 5-Years
42%
CAGR 10-Years
21%
Merit Medical Systems Inc
NASDAQ:MMSI
Other Current Assets
$31.3m
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
10%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.3B USD
Industry
Health Care

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is STAAR Surgical Co's Other Current Assets?
Other Current Assets
12.8m USD

Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Other Current Assets amounts to 12.8m USD.

What is STAAR Surgical Co's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
16%

Over the last year, the Other Current Assets growth was 2%. The average annual Other Current Assets growth rates for STAAR Surgical Co have been 18% over the past three years , 28% over the past five years , and 16% over the past ten years .

Back to Top